X

Trial Profile

A phase I trial of IW-1973 for the treatment of cardiovascular diseases

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 06 Oct 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Praliciguat (Primary)
Indications Cardiovascular disorders; Pulmonary arterial hypertension
Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics

Most Recent Events

18 Feb 2016 According to an Ironwood Pharmaceuticals media release, the company announced positive data of IW-1973 for the treatment of cardiovascular disorders.
18 Feb 2016 Status changed from recruiting to completed, according to an Ironwood Pharmaceuticals media release,
11 Jan 2016 According to an Ironwood Pharmaceuticals media release, results from this study are expected in 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com